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Aims: To gain new insights into the molecular mechanisms of action of doxazosin, we investigated the pros-
tatic stroma ultrastructure and the expression of genes involved with ﬁbrosis, such as collagen type I and III
(COL1A1 and COL3A1, respectively) and TGF-beta 1, in the rat ventral prostate.
Main methods: Adult Wistar rats were treated with doxazosin (25 mg/kg/day), and the ventral prostates
were excised at 7 and 30 days after treatment. Untreated rats were controls. Ventral prostates were subjected
to ultrastructural, immunohistochemical, biochemical and molecular analyses.
Key ﬁndings: Doxazosin-treated prostates showed thickened bundles of collagen ﬁbrils, activated ﬁbroblasts,
enlarged neurotransmitter vesicles and increased tissue immunostaining for collagen type I and type III when
compared to untreated prostates. After 7 and 30 days of doxazosin treatment mRNA expression of COL1A1
and COL3A1 was signiﬁcantly increased and reduced, respectively, compared to the control group.
TGF-beta 1 mRNA and protein levels were increased after 7 days of doxazosin treatment, whereas only
mRNA levels remained increased after 30 days of treatment.
Signiﬁcance: Our data suggest that relaxation of smooth muscle cells by alpha-blockers interferes with the
mechanical dynamics of the prostatic stroma extracellular matrix components, generating a pro-ﬁbrotic
effect probably via the TGF-beta 1 signaling pathway. Long term treatment with doxazosin may also lead
to a reduced turnover of extracellular matrix components. Our results add to a better understanding of the
molecular mechanisms behind the effects of alpha-blockade on prostatic histoarchitecture and the response
to treatment for benign prostatic hyperplasia.© 2012 Elsevier Inc. Open access under the Elsevier OA license.Introduction
Although the major function of the prostate gland is performed by
the secretory epithelium, it is well known that the stromal compart-
ment plays a crucial role in the structural support and in the mainte-
nance of the differentiated state of epithelial cells (Marker et al., 2003).
Fibroblasts and smoothmuscle cells (SMC) synthesize, organize and
maintain a complex extracellular network in the prostate stroma (Knox
et al., 1994; Nagle, 2004). The collagen proteins are some of the most
important extracellular matrix (ECM) macromolecules (Hynes, 2009),
and their rates of synthesis, accumulation and degradation are crucial
for prostate structure and function (Myllyharju and Kivirikko, 2001).
The main collagen proteins found in the prostatic stroma are types I,
III, IV, VI and VII (Sinha et al., 1991; Knox et al., 1994; de Carvalho
et al., 1997a; Vilamaior et al., 2000; Taboga and Vidal, 2003). Fibers of
the elastic system, hyaluronan, proteoglycans and others glycoproteins
are also present (Knox et al., 1994; de Carvalho et al., 1997b) anda, Instituto de Biosciencias, Univ
l. Tel./fax: +55 14 3880 0474.
.
sevier OA license.contribute to the dynamic epithelium-stroma cross-talk via paracrine
signals that regulate the behavior of both epithelial and stromal cells
(Marker et al., 2003). Similarly, epithelial and stromal cells dynamically
interact with ECMmolecules so that changes in the ECMmicroenviron-
ment can lead to alterations in the physiology of both epithelial and
stromal cells (Nelson and Bissell, 2006).
Stromal cells and extracellular matrix components are altered
in prostatic diseases (Knox et al., 1994; Lee and Peehl, 2004). It is
known that the ﬁbrotic process is regulated by transforming growth
factor-beta 1 (TGF-beta 1), a growth factor that recruits proinﬂammatory
cells andﬁbroblasts to theﬁbrotic area, stimulating these cells to produce
cytokines and extracellular matrix components, like type I collagen
(Jimenez et al., 1994). However, the extent to which these alterations
are causes or consequence of prostatic diseases is unknown.
Alpha-1 adrenergic receptor blockers, such as doxazosin, inhibit
the binding of catecholamines (released from autonomous nerve
varicosities) to alpha-1 receptors on the membrane of smooth muscle
cells. Thus, they lead to relaxation of prostatic smooth muscle cells
and relieve the symptoms associated with benign prostatic hyperpla-
sia (BPH). Besides the direct action on the smooth muscle cells,
doxazosin has been shown to induce apoptosis in stromal and epithe-
lial prostatic cells, suggesting additional effects on the long-term
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et al., 1998). Although the mechanisms by which doxazosin induces
apoptosis are not clear, some studies suggest that apoptosis occurs as fre-
quently in normal cells as it does in tumor cells (Kyprianou et al., 2009).
Previous results from our laboratory demonstrated for the ﬁrst time
that doxazosin treatment increases deposition of collagen ﬁbers in the
rat prostate stroma (Justulin et al., 2008). Recently, Imamura et al.
(2010) found that patients treated orally with α1-blockers had accu-
mulation of collagen ﬁbers in the prostatic stroma. The authors
suggested that this structural change could be one of the factors
responsible for the development of resistance to this treatment. We
recently showed that ﬁbroblasts become more active and that smooth
muscle cells shift from a predominantly contractile to a more synthetic
phenotype under α-adrenergic blockade by doxazosin (Delella and
Felisbino, 2010). However, doxazosin treatment also reduced the
weight and volume of the prostate gland. Thus, additional studies
using molecular approaches are needed to evaluate if the increased
area of collagen ﬁbers observed after doxazosin treatment is due to
rearrangement of pre-existing ﬁbers in a smaller gland or de novo
synthesis of collagen.
Because the epithelium-stroma cross-talk is vital to prostate homeo-
stasis, and to gain new insights into themolecularmechanisms of action
of doxazosin on the prostatic stroma, we investigated the stroma ultra-
structural morphology and the expression of some genes involved in
the ﬁbrotic pathway, such as collagens type I and III and TGF-beta1 in
the rat ventral prostate.
Material and methods
Animals and doxazosin administration
Adult male 3-month-old Wistar rats (n=30) were maintained in a
controlled environment with free access to food and water. The
experiment was performed according to the Guide for Care and Use of
Laboratory Animals. The animals were divided into two groups: control
rats and the doxazosin-treated group. Doxazosin-treated animals
received daily doses of doxazosin (Doxazosin mesylate, Pﬁzer, Galena
Pharmaceutical and Chemistry, SP, Brazil) at 25 mg/kg of body weight
dissolved in corn oil as vehicle by oral gavage. The dosage and duration
of treatments were determined by consulting with Pﬁzer and have pre-
viously been published (Yono et al., 2007). The control animals received
only the vehicle. After 7 and 30 days of treatment, 10 animals from each
group were euthanized by an overdose of pentobarbital. The ventral
prostates were excised and immediately weighed, and the left and
right lobes were snap frozen or immersed in ﬁxative.
Transmission electron microscopy
The ventral prostates tissue fragments of animals from each ex-
perimental group were immersed in 2.5% glutaraldehyde with 0.25%
tannic acid solution in Millonig's buffer for 2 hours (Cotta-Pereira
et al., 1976), washed, and post ﬁxed in 1% osmium tetroxide in the
same buffer for 1 hour. Tissue fragments were then washed again,
dehydrated in graded acetone, and embedded in Araldite. Semithin
sections were stained with Toluidine Blue and were analyzed under
light microscopy. Ultrathin silver sections were obtained with a dia-
mond knife and were contrasted with 2% alcoholic uranyl acetate
followed by 2% lead citrate in 1 N sodium hydroxide solution for
10 minutes. The grids were examined under a Phillips transmission
electron microscope operating at 80 kV.
Morphometric analysis
The transmission electron microscopy images of axonal varicosities
from each experimental group were used for morphometric analysis
to determine the mean diameter of the neurotransmitter vesicles.Random interactive measurements were performed for at least 30
vesicles per image from two different images of ﬁve distinct animals
at a magniﬁcation of 60,000× (a minimum of 300 measurements
per experimental group) using Leica Q-win software Version 3 for
WindowsTM.
Immunohistochemistry
The ventral prostate frozen sections (7 μm) were collected on
silanized glass slides andﬁxed in coldmethanol for 10 minutes. Sections
were then blocked with 3% hydrogen peroxide in methanol for 15 mi-
nutes (to block endogenous peroxidase activity) before blocking with
3% bovine serum albumin in PBS for 1 hour at room temperature. The
sections were incubated with the following primary monoclonal
antibodies for 2 hours at room temperature: Type I Collagen, 1:300,
Genetex, GTX 26308; Type III Collagen, 1:300, Abcam, ab 6310;
TGF-beta 1, 1:100, Santa Cruz, sc-146; Alpha Actin, 1:300, Santa Cruz,
sc-32251. The primary antibody was detected using a secondary
peroxidase-conjugated antibody (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), except for TGF-beta 1, which was detected using the
Mach 4 Universal HRP-Polymer Kit with DAB (BiocareMedical, Concord,
CA, USA). Chromogen color development was accomplished with
3.3′-diaminobenzidine tetrahydrochloride (Sigma, USA). Slides were
counterstained with Harris's hematoxylin. The negative control was
performed by excluding the primary antibody incubation step.
Protein extraction and western blotting analysis for TGF-beta 1
The ventral prostates frozen samples were mechanically homoge-
nized in 50 mM Tris–HCl buffer pH 7.5, 0.25% Triton X-100 and EDTA
bymeans of a Polytron homogenizer (Kinematica, Lucerne, Switzerland)
for 30 s at 4 °C. Following centrifugation of the homogenate, the protein
was extracted from the supernatant and was quantiﬁed as described by
Bradford (1976). Equal amounts of protein (75 μg) from the ventral
prostate frozen samples were heated at 95 °C for 5 minutes in the
sample-loading buffer and were then subjected to SDS–PAGE under
reducing conditions and were transferred to nitrocellulose membranes
(Sigma Chemical Co., St. Louis, MO). The blots were blocked with 3%
bovine serum albumin in TBST (10 mM Tris–HCl pH 7.5, 150 mM
NaCl, 0.1% Tween-20) for 1 hour andprobed overnightwith the primary
antibody, anti-TGF-beta 1 (1:1,000; MAB240; R&D Systems, Minneapo-
lis, USA). Goat anti-β-actin antibody (1:1,000; Santa Cruz Biotechnology,
Santa Cruz, CA, USA) served as loading control. After incubation with
the corresponding horseradish peroxidase-conjugated secondary anti-
bodies, the blots were detected by means of chemiluminescence
(Pierce® ECL Western Blotting Substrate). TGF-beta 1 and β-actin pro-
tein expression was quantiﬁed by densitometric analysis of the bands
and was expressed as integrated optical density (IOD). The TGF-beta 1
expression was normalized to the β-actin values. Normalized data are
expressed as the means±SD.
Collagen I, collagen III and TGF-beta 1 mRNA expression
Total RNA was isolated from ventral prostate samples using TRIzol
Reagent (Invitrogen Life Technologies, Carlsbad, CA, USA), according
to the manufacturer's speciﬁcations. The RNA concentration (μg/μL)
was determined in each sample using a NanoDrop® ND-1000 UV–
vis Spectrophotometer (Nanodrop Technologies, Wilmington, DE,
USA). The RNA purity was ensured by obtaining a 260/280 nm OD
ratio equal to 2.0. Total RNA (2 μg) was treated with Ampliﬁcation
Grade Deoxyribonuclease I according to the protocol provided by
Invitrogen (Life Technologies Corporation, Carlsbad, CA, USA). The
puriﬁed total RNA was reverse transcribed with random hexamer
primers using a High-Capacity cDNA Archive Kit (Life Technologies
Corporation, Carlsbad, CA, USA). Type I collagen, type III collagen
and TGF-beta 1 gene expression levels were detected for each
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Foster City, CA, USA). Reactionswere performed in duplicate, including
no-template controls to conﬁrm that themastermixwas free from con-
taminants. The RT-qPCR conditions were 10 minutes at 95 °C followed
by 40 cycles of denaturation at 95 °C for 15 seconds and annealing/
extension at 60 °C for 1 minute. The FAM-conjugated gene-speciﬁc
custom assays were: Rn01463848_m1 for the type I Procollagen α-1
gene, Rn01437683_m1 for the type III Procollagen α-1 gene and
Rn99999016_m1 for the Transforming Growth Factor 1 (TGF beta-1)
gene. A custom GAPDH (glyceraldehyde 3-phosphate dehydrogenase)
VIC-conjugated gene-speciﬁc assay (TaqMan 4352338E) was used as
a reference to normalize quantiﬁcation of mRNA targets. This gene
showed invariant expression across all samples (p=0.824).
RT-qPCR was performed for target and reference genes in the
same RT reaction using two replicates of each sample and a reference
gene. An ampliﬁcation plot graphically displayed the ﬂuorescence
detected over the number of cycles that were performed. Using the
2−ΔΔCt method, data were recorded as the fold-change in gene
expression normalized by the reference gene and relative to the cali-
brator sample (Livak and Schmittgen, 2001). All samples then were
normalized to the ΔCt value of a calibrator sample to obtain a ΔΔCt
value (ΔCttarget−ΔCtcalibrator). The control group was chosen as the
calibrator sample to evaluate target gene putative differential mRNA
expression relative to this group. Dissociation-melting curves con-
ﬁrmed the speciﬁc ampliﬁcation of the cDNA target and the absence
of nonspeciﬁc products.
Statistical analysis
One-way analysis of variance (ANOVA)was performed to determine
whether differences existed between groups (pb0.05) and the Tukey–
Kramer multicomparison post-test was employed. A p-value of b0.05
was considered signiﬁcant. The statistical tests were performed using
Instat (version 3.0; Graph-Pad, Inc., San Diego, CA, USA).
Results
Transmission electron microscopy investigation
The ultrastructural analysis showed that the ventral prostate
from control rats is composed by a thin stroma structured in a well-
organized pattern (Fig. 1a). The collagen ﬁbrils of the subepithelial stro-
mawere thin and sparsely distributed adjacent to ﬁbroblast extensions.
One or two layers of smoothmuscle cells surrounded the acini. Delicate
elastic ﬁbers and bundles of collagen ﬁbers ﬁlled the stroma betweenFig. 1. (a) Ultrastructure of the ventral prostate from control rats showing few and thin bundle
cells (smc) and ﬁbroblast cytoplasmic extensions (f). Elaunicﬁbers (white arrows). (b) Ventral p
with doxazosin for 30 days. Note the dense bundles of collagen ﬁbrils (black arrows) around sﬁbroblasts and smooth muscle cells. The smooth muscle cells showed
a regular and smooth outline (Fig. 1b).
Seven days of doxazosin treatment promoted activation of ﬁbro-
blasts (Fig. 1b), which contained large nuclei with loose chromatin
and evident nucleoli. The bundles of collagen ﬁbrils were denser
between the cells (Fig. 1b). At day 30 of dox treatment, ﬁbroblasts
and smooth muscle cells showed many cytoplasm extensions closely
associated with thickened bundles of collagen ﬁbrils (Fig. 1c).
Neurotransmitter vesicle diameter determination
The ultrastructural analysis showed many axonal varicosities ﬁlled
with neurotransmitter vesicles and mitochondria dispersed among
smooth muscle cells in the ventral prostate from control rats (Fig. 2a),
and from ventral prostate of rats treated with doxazosin for 7 (Fig. 2b)
and 30 days (Fig. 2c). Morphometrical analysis showed that 30 days
of doxazosin treatment signiﬁcantly increased the mean diameter of
the neurotransmitter vesicles (Fig. 3). At day 7, there was a trend
towards an increase in the diameter of neurotransmitter vesicles, but
without statistically signiﬁcant difference.
Type I and type III collagen analyses
To further examine the effects of doxazosin on major components
of the extracellular matrix, we assessed the mRNA and protein ex-
pressions of collagens type I and III. Type I collagen was found to be
dispersed throughout the stroma, surrounding glandular acini and
ducts in the ventral prostate from control rats (Fig. 4a). Doxazosin
treatment increased the density of type I collagen at day 7 (Fig. 4d)
and at day 30 of treatment (Fig. 4f), mainly around acini. Expression
of the mRNA for collagen type I (COL1A1) was transiently increased
at day 7, and decreased signiﬁcantly at 30 days of doxazosin treat-
ment (Fig. 7). Type III collagen was found distributed in the intersti-
tial stroma, ﬁlling epithelial infoldings and around blood vessels
(Fig. 4c) of the ventral prostate stroma from control rats. The α-1
adrenergic blockade also increased the distribution of collagen type
III at day 7 (Fig. 4e) and day 30 (Fig. 4g) of the treatment, mainly
below the epithelium. Expression of the mRNA for collagen type III
(COL3A1) was also transiently increased at day 7, and was signiﬁcant-
ly decreased at day 30 (Fig. 7).
TGF-beta 1 expression
To evaluate TGF-beta 1 localization, mRNA and protein expression
in the ventral prostate from control and doxazosin-treated rats, we
used immunohistochemistry, real time quantitative PCR and westerns of collagen ﬁbrils (black arrows) above the epithelium (ep) and around smooth muscle
rostate from a rat treatedwith doxazosin for 7 days. (c) Ventral prostate from a rat treated
mooth muscle cells (smc) and active ﬁbroblasts (f). Scale bars=1 μm.
Fig. 2. Ultrastructure of the rat ventral prostate from control (a), doxazosin-treated for 7
(b) and 30 days (c) showing neurotransmitter vesicles inside the axonal varicosities
dispersed among smooth muscle cells. Note the increased diameter of neurotransmitter
vesicles after doxazosin treatment (arrows). Scale bars=400 nm.
Fig. 3.Mean diameter of neurotransmitter vesicles of the ventral prostate from control,
doxazosin day 7 and doxazosin day 30 rats, assessed by morphometry. Values are
mean±SD. *Statistically different from control and from doxazosin day 7 with pb0.05.
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lial and stromal compartments in the ventral prostate from control
rats (Fig. 5a). Doxazosin treatment increased TGF-beta 1 immuno-
staining at day 7 (Fig. 5b), which returned to levels similar to that
found in ventral prostate from control rats at day 30 (Fig. 5c).
Fig. 6a shows a representative western blot for TGF-beta 1 from
the ventral prostate of control and the doxazosin-treated rats. The
speciﬁc immunoreactive band for TGF-beta 1 (25 kDa) was more in-
tense in the ventral prostate from rats treated with doxazosin for
7 days (pb0.05) when compared to controls (Fig. 6b).
The results of the q-RT-PCR for TGF-beta 1 are shown in Fig. 7.
Doxazosin treatment signiﬁcantly increased TGF-beta 1 mRNA ex-
pression at day 7 (pb0.01), which returned to levels observed in con-
trols at day 30.
Discussion
Alpha 1-adrenergic receptor blockers obstruct the adrenergic re-
ceptors, which are abundant in smooth muscle cells of the prostate
and bladder, resulting in a reduction of smooth muscle tone andhave been a safe and efﬁcacious pharmacological treatment option
for patients suffering from BPH (AUA, 2003; Caine, 1986).
The quilinazole-based class of α-adrenoceptor blockers, such as
doxazosin, has the additional effect of inducing apoptosis of prostate
cells, which has been demonstrated to be involved in the long-term ef-
ﬁcacy of treatments for BPH (Anglin et al., 2002; Chiang et al., 2005;
Kyprianou, 2003; Kyprianou et al., 1998; Yang et al., 1997). The induc-
tion of apoptosis in prostate cells by doxazosin has been attributed to
an increased expression of TGF beta-1 (Glassman et al., 2001; Ilio
et al., 2001; Partin et al., 2003; Yang et al., 1997). However, Zhao et al.
(2005), using a molecular approach, showed an involvement of TNF-
alpha in the doxazosin molecular mechanism of action and disproved
the participation of the TGF-beta 1 pathway in doxazosin-induced
apoptosis in stromal cells. Thus, more studies are needed to better
understand the direct and indirect effects of doxazosin treatment on
prostatic tissue cells apoptosis.
Although the involvement of TGF-beta 1 in doxazosin-induced apo-
ptosis is still controversial, there is no doubt that this multifunctional
cytokine regulates extracellular matrix production and degradation
(Fleisch et al., 2006;Mauviel, 2005; Roberts et al., 1990). Our laboratory
has been focused on the changes in the prostatic stroma induced by
doxazosin treatment, with special attention to the extracellular matrix
components. We have previously demonstrated that doxazosin treat-
ment increases both collagen and elastic system ﬁber volume fractions
in the stroma of the rat prostatic complex (Delella and Felisbino, 2010;
Justulin et al., 2008).
In the present study, we showed that 7 days of doxazosin treatment
signiﬁcantly increased the mRNA and protein expressions of collagen
type I and III and TGF beta-1 in the rat ventral prostate. Our results are
in agreementwith previous results of total collagen ﬁbers quantiﬁcation
by picrosirius staining coupled tomorphometric analyses (Justulin et al.,
2008). Moreover, the ultrastructural ﬁndings clearly showed thickened
bundles of collagen ﬁbrils around stromal cells in the ventral prostate
from doxazosin-treated rats. Together, these data suggest an early
proﬁbrotic effect of doxazosin on prostate stroma via TGF beta-1 signal-
ing. Although rodent models present some limitations and no entirely
results can be applied for studying human BPH, they provide interesting
information about the behavior of the prostatic tissue under several dif-
ferent experimental conditions and shed light on the molecular mecha-
nisms behind it. In this sense, our results using rats corroborate the
ﬁndings of Imamura et al. (2010) that have addressed the effect
of doxazosin treatment on collagen ﬁbers deposition in the human
hyperplasic prostate gland. As observed in our study, these authors
have found an increased amount of collagen ﬁbers in a group of patients
treated by doxazosin and suggested that this stromal alteration may be
related to reduction in the long-term effectiveness of the treatment.
Fig. 4. Immunohistochemistry for collagens type I and III on sections from the ventral prostate of rats from control (a–c), doxazosin day 7 (d and e) and doxazosin day 30 groups (f and g).
b: Negative control. a, d and f: Type I collagen. c, e and g: Type III collagen. Positive reaction for collagen types was observed in the interstitial stroma (asterisks) and in the thin periacinar
stroma (arrows). Note the increased intensity of immunoreaction for collagen types in the prostate from doxazosin-treated rats. Scale bars: a, c–g=50 μm; b=10 μm.
1285F.K. Delella et al. / Life Sciences 91 (2012) 1281–1287Notably, mRNA expression for both collagens I and III was signiﬁ-
cantly decreased after 30 days of doxazosin treatment, whereas
TGF-beta 1 mRNA, but not the protein, remained increased. This late
effect of doxazosin on collagen mRNA expression suggests a reduc-
tion in the turnover of these proteins by stromal cells. These results
reinforce the importance of evaluating different times of exposure
to a better understanding of doxazosin effects on the prostate gland.
The consequence of this late down regulation of collagen mRNA
expression by doxazosin for the maintenance of normal prostatic
stroma homeostasis and for the epithelium-stroma interactions still
needs to be determined and is currently under investigation by our
laboratory.
The morphology of stromal cells was also affected by alpha1
blockade. We showed previously that prostatic smooth muscle cells
exhibited a synthetic phenotype (Delella and Felisbino, 2010) after
doxazosin treatment. Smooth muscle cells are known to reversibly
switch phenotypes between a synthetic and a contractile state(Halayko et al., 2008; Zhou et al., 2009). Smith et al. (1999) showed
that doxazosin decreased the contractility and expression of actin
and myosin proteins in prostatic smooth muscle cells in vitro. This
suggests that alpha1-blockers may induce dedifferentiation of
smooth muscle cells into ﬁbroblasts and myoﬁbroblasts. However, if
this possible dedifferentiation occurs in vivo remains to be deter-
mined. In the present study, we observed activated ﬁbroblasts with
enlarged cytoplasm and loose chromatin after 7 days of doxazosin
treatment. Activated ﬁbroblasts are in agreement with the up regula-
tion of collagen mRNA and TGF-beta 1 protein observed at this period
of the treatment. Furthermore, ﬁbroblast phenotype at 30 days of
doxazosin treatment is also in agreement with the down regulation
of collagen mRNA and the normalization of TGF-beta 1 proteins. To-
gether, these results reinforce our previous hypothesis (Delella and
Felisbino, 2010; Justulin et al., 2008) that the reduction of smooth
muscle cell tonus induced by doxazosin treatment promotes changes
in the prostatic tissue mechanical properties, leading to extracellular
Fig. 5. Immunohistochemistry for TGF-beta 1 protein in the rat ventral prostate. (A) Control; (B) doxazosin day 7; (C) doxazosin day 30. Note the positive immunostaining for
TGF-beta 1 in the epithelial and stromal compartments (arrows), which is increased in the doxazosin day 7 group. Bars=10 μm.
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pose that this stromal remodeling following doxazosin treatment
may be detrimental for BPH therapy, since it increases the static com-
ponent of the prostatic tissue that does not respond to alpha blockers
(Imamura et al., 2010). Since quinazoline derivatives has alpha-1
adrenoceptor independent effects, future studies from our laboratory
will evaluate our hypothesis using Tamsulosin, a non-quinazoline
selective α-adrenergic antagonist that has more speciﬁcity for α-1A
and α-1D receptor subtypes.
Curiously, phenylephrine treatment, a selective α1-adrenergic
receptor agonist, did not exhibit opposite effect than doxazosin with
regards to ﬁbrosis. Previous studies showed that phenylephrine treat-
ment induced atypical prostatic hyperplasia and mild ﬁbrosis in the
rat ventral prostate (Golomb et al., 1998; Rosenzweig et al., 2004;
Rosenzweig-Bublil and Abramovici, 2006). These effects have been
related to a tissue repair process occurring subsequent to the inﬂam-
matory exudates that takes place during early period of phenyleph-
rine treatment.Fig. 6. (A) Representative western blot analyses of TGF-beta 1 and β-actin (Actin) in
homogenates from ventral prostates (lane 1=control; lane 2=doxazosin day 7;
lane 3=doxazosin day 30). Seventy ﬁve micrograms of protein was loaded into each
lane (15 μg from ﬁve different individual homogenates). (B) Relative expression
(IOD integrated optical density) of TGF-beta 1 and β-actin (loading control) (Fig. a).
TGF-beta 1 was detected in the ventral prostate from all groups and was increased in
the doxazosin day-7 group (Fig. B). Data are as mean±SD. *Statistically signiﬁcant
different from control with pb0.05.As the human prostate, the rat ventral prostate is largely innervated
by both the sympathetic and parasympathetic nervous system (Vaalasti
and Hervonen, 1979, 1980). The contraction of the smoothmuscle cells
that surround acini and ducts is under sympathetic control, and its
activation initiates the contractile function of the genital duct system
and the prostatic muscular element (Bruschini et al., 1978). It is well
known that doxazosin is a selective alpha 1 blocker that occupies
the alpha 1 adrenoceptor site for norepinephrine, thereby inhibiting
smooth muscle contraction (Lepor, 2007). Our study showed for the
ﬁrst time that alpha blockade increases the size of neurotransmitter
vesicles inside the axonal varicosities dispersed along smooth muscle
cells. It is known that after exocytosis, norepinephrine may be
transported back into synaptic vesicles by the norepinephrine trans-
porter and the vesicular monoamine transporter (Eisenhofer, 2001).
However, how doxazosin is involved in this process remains to be
determined. Our results encourage future studies to investigate if
doxazosin and other alpha-blockers may increase norepinephrine
reuptake into axonal varicosities and vesicles.
Conclusion
In summary, our data suggest that relaxation of smoothmuscle cells
by treatment with an alpha-blocker modulates collagen mRNA expres-
sion in the prostatic stroma via the TGF-beta 1 signaling pathway,
leading to a marked remodeling of cellular and extracellular elements
of the prostate stroma. Our results contribute to a better understandingFig. 7. Collagens type I (COL1A1) and III (COL3A1) and TGF-beta 1 mRNA expression as
quantiﬁed by qRT-PCR in the ventral prostate of rats treated with doxazosin for 7 and
30 days. Levels of COL1A1 and COL3A1 and TGF-beta 1 mRNA were signiﬁcantly up
regulated at day 7 of treatment and down regulated at day 30. The target genes were
normalized to the level of the housekeeping gene GAPDH. Data are signiﬁcantly differ-
ent from control group at pb0.05 (*), pb0.01 (**) and pb0.001 (***).
1287F.K. Delella et al. / Life Sciences 91 (2012) 1281–1287of the molecular mechanisms of action of alpha-blockade on prostate
histoarchitecture and the response to BPH treatment.
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